These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
480 related items for PubMed ID: 18187388
1. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. McCullough ML, Patel AV, Patel R, Rodriguez C, Feigelson HS, Bandera EV, Gansler T, Thun MJ, Calle EE. Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388 [Abstract] [Full Text] [Related]
2. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Chang SC, Lacey JV, Brinton LA, Hartge P, Adams K, Mouw T, Carroll L, Hollenbeck A, Schatzkin A, Leitzmann MF. Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763 [Abstract] [Full Text] [Related]
3. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):822-8. PubMed ID: 12223425 [Abstract] [Full Text] [Related]
4. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women. Wang Y, Jacobs EJ, Teras LR, Pavluck AL, Rodriguez C, Thun MJ, Calle EE. Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155 [Abstract] [Full Text] [Related]
6. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ, Calle EE. Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283 [Abstract] [Full Text] [Related]
7. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study. Akesson A, Julin B, Wolk A. Cancer Res; 2008 Aug 01; 68(15):6435-41. PubMed ID: 18676869 [Abstract] [Full Text] [Related]
8. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study. Rea TD, Psaty BM, Heckbert SR, Cushman M, Meilahn E, Olson JL, Lemaitre RN, Smith NL, Sotoodehnia N, Chaves PH. J Womens Health (Larchmt); 2003 May 01; 12(4):341-50. PubMed ID: 12804341 [Abstract] [Full Text] [Related]
9. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Cancer Epidemiol Biomarkers Prev; 2005 Feb 01; 14(2):459-66. PubMed ID: 15734973 [Abstract] [Full Text] [Related]
10. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, Thun MJ, Calle EE. Cancer Epidemiol Biomarkers Prev; 2007 Jan 01; 16(1):63-9. PubMed ID: 17179486 [Abstract] [Full Text] [Related]
11. Diabetes and endometrial cancer in the Iowa women's health study. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, Lazovich D, Folsom AR. Cancer Epidemiol Biomarkers Prev; 2001 Jun 01; 10(6):611-6. PubMed ID: 11401910 [Abstract] [Full Text] [Related]
12. Hormone therapy and breast cancer: what factors modify the association? Gertig DM, Fletcher AS, English DR, Macinnis RJ, Hopper JL, Giles GG. Menopause; 2006 Jun 01; 13(2):178-84. PubMed ID: 16645531 [Abstract] [Full Text] [Related]
13. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Obstet Gynecol; 1995 Feb 01; 85(2):304-13. PubMed ID: 7824251 [Abstract] [Full Text] [Related]
14. Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones. Stevens VL, Jacobs EJ, Patel AV, Sun J, Gapstur SM, McCullough ML. Cancer Causes Control; 2014 Mar 01; 25(3):321-8. PubMed ID: 24381074 [Abstract] [Full Text] [Related]
15. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States). Li CI, Malone KE, Daling JR. Cancer Causes Control; 2006 Jun 01; 17(5):695-703. PubMed ID: 16633917 [Abstract] [Full Text] [Related]
16. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DS, Barlow WE, Cutter G, Geller BM, Yankaskas B, Taplin SH, Carney PA. J Clin Oncol; 2003 Dec 01; 21(23):4314-21. PubMed ID: 14645420 [Abstract] [Full Text] [Related]
17. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group. Brinton LA, Hoover RN. Obstet Gynecol; 1993 Feb 01; 81(2):265-71. PubMed ID: 8380913 [Abstract] [Full Text] [Related]
18. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Strom BL, Schinnar R, Weber AL, Bunin G, Berlin JA, Baumgarten M, DeMichele A, Rubin SC, Berlin M, Troxel AB, Rebbeck TR. Am J Epidemiol; 2006 Oct 15; 164(8):775-86. PubMed ID: 16997897 [Abstract] [Full Text] [Related]
19. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Wolf LA, Terry PD, Potter JD, Bostick RM. Cancer Epidemiol Biomarkers Prev; 2007 Apr 15; 16(4):676-83. PubMed ID: 17416757 [Abstract] [Full Text] [Related]
20. Hormone replacement therapy use and variations in the risk of breast cancer. Opatrny L, Dell'Aniello S, Assouline S, Suissa S. BJOG; 2008 Jan 15; 115(2):169-75; discussion 175. PubMed ID: 18081598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]